HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$5.17
Day range
$5.01 - $5.22
Year range
$4.25 - $9.01
Market cap
372.46M USD
Avg Volume
1.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.74M | 94.38% |
Net income | -29.50M | -109.59% |
Net profit margin | — | — |
Earnings per share | -0.29 | -25.58% |
EBITDA | -15.58M | -98.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 119.73M | 16.64% |
Total assets | 125.20M | 17.15% |
Total liabilities | 73.27M | 80.75% |
Total equity | 51.92M | — |
Shares outstanding | 73.25M | — |
Price to book | 5.44 | — |
Return on assets | -35.98% | — |
Return on capital | -41.81% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -29.50M | -109.59% |
Cash from operations | -10.57M | -81.77% |
Cash from investing | -409.00K | -13,533.33% |
Cash from financing | 43.90M | -52.24% |
Net change in cash | 32.92M | -61.77% |
Free cash flow | -5.62M | -129.88% |
About
Founded
2003
Headquarters
Website
Employees
55
